The immunoreactivity of β1-adrenergic receptors (ADRB1) has been detected but not overexpressed in tumor cells, suggesting that ADRB2 plays a leading role in lung cancer compared with other beta-adrenergic receptors. Here, ADRB1 is linked to lung carcinoma.